New pill may help diabetics fast safely during ramadan
NCT ID NCT07613307
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a once-daily pill called orforglipron in adults with type 2 diabetes who plan to fast during Ramadan. The goal is to see if the drug helps control blood sugar and weight without causing harm. About 130 participants will take the pill for up to 48 weeks, with clinic and virtual visits.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BEHAVIOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Aliwal Shoal Medical Centre
eMkhomazi, 4170, South Africa
-
Apollo Multispeciality Hospitals limited
Kolkata, 700054, India
-
Be Part Research (PTY) LTD
Paarl, 7626, South Africa
-
Brij Medical Centre Pvt. Ltd.
Kanpur, 208020, India
-
Diabetes Clinic
Nellore, 524001, India
-
Dr JM Engelbrecht Trial Site
Somerset West, 7130, South Africa
-
Dr. Soliman Fakeeh Hospital
Jeddah, 21461, Saudi Arabia
-
Dr. Soliman Fakeeh Hospital
Riyadh, 11564, Saudi Arabia
-
Drs H & V Makan Centre for Diabetes
Lenasia, 1827, South Africa
-
Dubai Hospital
Dubai, 7272, United Arab Emirates
-
Emirates Hospital Dubai
Dubai, 0000, United Arab Emirates
-
Emmed Research
Pretoria, 0002, South Africa
-
Fola Health
Johannesburg, 2091, South Africa
-
JOSHA Research
Bloemfontein, 9301, South Africa
-
KGN Diabetes and Endocrinology Centre
Mumbai, 400008, India
-
King Abdulaziz University Hospital
Jeddah, 22254, Saudi Arabia
-
King Abdulaziz University for Health Sciences Ministry of National Guard Health Affairs
Al-Ahsa, 31982, Saudi Arabia
-
King Fahad Armed Forces Hospital Jeddah
Jeddah, 23311, Saudi Arabia
-
King Fahad Specialist Hospital
Dammam, 32253, Saudi Arabia
-
King Saud University Medical City
Riyadh, 11472, Saudi Arabia
-
Mysore Medical College and Research Institute
Mysore, 570001, India
-
NMC Abu Dhabi
Abu Dhabi, 6222, United Arab Emirates
-
National Guard Health Affairs: King Abdulaziz Medical City
Jeddah, 21423, Saudi Arabia
-
Osepdale Fatebenefratelli e Oftalmico
Riyadh, 12231, Saudi Arabia
-
Osmania General Hospital
Hyderabad, 500012, India
-
Sarojini Naidu Medical College
Agra, 282003, India
-
Sheikh Khalifa Medical City
Abu Dhabi, 0000, United Arab Emirates
-
Supe Heart & Diabetes Hospital & Research Centre
Nashik, 422002, India
-
Synergy Biomed Research Institute (SBRI)
East London, 5201, South Africa
-
Synopsis Research
Cape Town, 7708, South Africa
-
TASK Central
Cape Town, 7530, South Africa
-
TREAD Research
Cape Town, 7500, South Africa
-
Tawam Hospital
Al Ain City, 15258, United Arab Emirates
-
Tiervlei Trial Centre
Cape Town, 7530, South Africa
-
Trident Clinical
Kimberley, 8301, South Africa
-
Ubuntu Clinical Research Krugersdorp
Krugersdorp, 1739, South Africa
-
Visakha Institute of Medical Sciences
Visakhapatna, 530040, India
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Daily pill could offer new hope for weight loss in east asian adults
- Blood test could predict who faces rapid kidney decline in diabetes
- Blood test may predict kidney decline in diabetes — a large trial investigates
- Hormone clue may unmask kidney danger in diabetes
- Can a heart drug tame blood sugar and weight in diabetes?
- Can a single pill tackle both fatty liver and diabetes?